Revance Therapeutics, Inc. (RVNC)

Last Closing Price: 3.95 (2024-05-03)

Earnings Announcements: Estimated vs Actual

On 2024-02-28, Revance Therapeutics, Inc. (RVNC) announced earnings per share of $-0.62 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.79.

The next expected annoucement date for quarterly earnings is 2024-05-09, with an average estimated earnings per share of $-0.66 for the fiscal quarter ending 2024-03-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2024-02-28 2023-12-31 $-0.79 $-0.62
2023-11-08 2023-09-30 $-1.02 $-0.74
2023-08-08 2023-06-30 $-0.72 $-0.80
2023-05-09 2023-03-31 $-0.75 $-0.74
2023-02-28 2022-12-31 $-1.04 $-1.82
2022-11-08 2022-09-30 $-0.85 $-1.17
2022-08-09 2022-06-30 $-0.91 $-0.88
2022-05-10 2022-03-31 $-0.91 $-0.94
2022-02-28 2021-12-31 $-0.98 $-0.93
2021-11-09 2021-09-30 $-1.15 $-1.10
2021-08-05 2021-06-30 $-1.14 $-1.07
2021-05-10 2021-03-31 $-1.19 $-1.08
2021-02-22 2020-12-31 $-1.25 $-1.24
2020-11-09 2020-09-30 $-1.09 $-1.34
2020-08-06 2020-06-30 $-0.96 $-1.12
2020-05-07 2020-03-31 $-0.91 $-1.15
2020-02-24 2019-12-31 $-0.94 $-0.99
2019-11-04 2019-09-30 $-0.96 $-0.96
2019-08-05 2019-06-30 $-0.86 $-0.86
2019-05-08 2019-03-31 $-0.83 $-0.85
2019-02-26 2018-12-31 $-0.94 $-1.12
2018-11-01 2018-09-30 $-0.95 $-0.91
2018-08-02 2018-06-30 $-0.92 $-0.94
2018-05-08 2018-03-31 $-0.63 $-0.97
2018-02-28 2017-12-31 $-0.98 $-1.14
2017-11-02 2017-09-30 $-0.93 $-1.01
2017-08-03 2017-06-30 $-0.93 $-0.90
2017-05-09 2017-03-31 $-0.84 $-0.94
2017-02-27 2016-12-31 $-0.82 $-0.95
2016-11-03 2016-09-30 $-0.90 $-0.64
2016-08-04 2016-06-30 $-0.83 $-0.88
2016-05-09 2016-03-31 $-0.87 $-0.71
2016-03-02 2015-12-31 $-0.92 $-0.83
2015-11-09 2015-09-30 $-1.01 $-0.81
2015-08-06 2015-06-30 $-0.76 $-0.71
2015-05-13 2015-03-31 $-0.69 $-0.65
2015-03-02 2014-12-31 $-0.53 $-0.60